Zhenlei Zhang

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Induced Apoptosis

Pseudomonas Aeruginosa

Human Serum Albumin

Top Venues

Journal of medicinal chemistry

Dalton transactions (Cambridge, England : 2003)

Molecular pharmaceutics

This page only lists publications with an associated author ORCID identifier.

Publications

Ming Jiang, Wenjuan Li, Jinzhe Liang, Min Pang, Shanhe Li, Gang Xu, Minghui Zhu, Hong Liang, Zhenlei Zhang, Feng Yang
Developing a Palladium(II) Agent to Overcome Multidrug Resistance and Metastasis of Liver Tumor by Targeted Multiacting on Tumor Cell, Inactivating Cancer-Associated Fibroblast and Activating Immune Response. Journal of medicinal chemistry (2024)
Zhenlei Zhang, Juzheng Zhang, Tongfu Yang, Shanhe Li, Gang Xu, Hong Liang, Feng Yang
Developing an Anticancer Platinum(II) Compound Based on the Uniqueness of Human Serum Albumin. Journal of medicinal chemistry (2023)
Shihang Xu, Weicong Luo, Minghui Zhu, Lei Zhao, Lijuan Gao, Hong Liang, Zhenlei Zhang, Feng Yang
Human Serum Albumin-Platinum(II) Agent Nanoparticles Inhibit Tumor Growth Through Multimodal Action Against the Tumor Microenvironment. Molecular pharmaceutics (2023)
Ming Jiang, Tongfu Yang, Yong Chu, Zhenlei Zhang, Hongbin Sun, Hong Liang, Feng Yang
Design of a novel Pt(II) complex to reverse cisplatin-induced resistance in lung cancer via a multi-mechanism. Dalton transactions (Cambridge, England : 2003) 51 (13) (2022)